MANOUCHEHR LAVIAN: Open Payments
NPI 1013922491 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,569 in 46 payments from 10 companies in 2025. Trend: 2023 $1,178 · 2024 $751 · 2025 $1,569
Food & beverage: $1,565Education: $4
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $294 |
| Axsome Therapeutics, Inc. | 3 | $266 |
| Alkermes, Inc. | 8 | $239 |
| Neurocrine BioSciences, Inc. | 5 | $235 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $116 |
| Lundbeck LLC | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| HARMONY BIOSCIENCES LLC | 1 | $47 |
Products named: VRAYLAR, Auvelity, INGREZZA, REXULTI, LYBALVI, UZEDY, TRINTELLIX, ARISTADA.
Industry payments across NY — which companies pay providers there.
